About
NI Medical is a biotechnology company and a leading developer and manufacturer of whole body bioimpedance systems, the Non Invasive Cardiac System (NICaS) and the Hemodynamic Navigator. Its goal is to provide non-invasive solutions to the various challenges in the cardiovascular field. These range from Hypertension, Chronic heart failure, Hemodialysis, ICU/ICCU, Neonatal, Obstetrics & Gynecology, and treatment of infectious diseases.
The NI Medical NICaS System provides a much-needed solution for non-invasive hemodynamic and fluid management in both inpatient and outpatient settings.
NI Medicals products have been certified worldwide with U.S. FDA 510(k), European CE mark, Canadian MDL, Japanese PMDA (Shonin), and Israeli AMAR approvals.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is NI Medical's primary focus?
- NI Medical is a biotechnology company that develops and manufactures whole-body bioimpedance systems, specifically the Non Invasive Cardiac System (NICaS) and the Hemodynamic Navigator, for non-invasive cardiovascular solutions.
- Where is NI Medical headquartered?
- NI Medical is headquartered in Petah Tikva, Israel.
- When was NI Medical founded?
- NI Medical was founded in August 2011.
- What certifications do NI Medical's products hold?
- NI Medical's products have received worldwide certifications including U.S. FDA 510(k), European CE mark, Canadian MDL, Japanese PMDA (Shonin), and Israeli AMAR approvals.
- What is the approximate employee count for NI Medical?
- NI Medical currently has between 11 and 50 employees, with an exact count of 43.
- What significant partnership did NI Medical announce in November 2022?
- In November 2022, NI Medical joined the Innovators' Network at the American Heart Association Center for Health Technology & Innovation.
- Did NI Medical sign a deal in the US in 2013?
- Yes, in August 2013, NI Medical signed a US health monitor deal.
- Has NI Medical's technology been used in European heart studies?
- Yes, in October 2010, NI Medical's technology was announced for use in a major European heart study.